Days

0

Speakers

0

Delegates

0

Clinics

0

Gala Dinner

0

Hosts

Partners

The conference content is managed by a team of highly distinguished, foremost experts based at the world renowned Moorfields Eye Hospital and UCL Institute of Ophthalmology.
The very best ophthalmologists, researchers, vision scientists and geneticists from around the globe will showcase the latest work on all aspects of aniridia.

The 5th EAC, like its predecessors, will discuss their amazing surgery and experiments relating to aniridia. Colleagues and people affected will attend to share their perspectives and disseminate the learning back in their own countries.

Find out more about our hosts and partners
Partners

Sponsors

We’re seeking sponsors to make this event happen and so play a key role in preventing sight loss, improving the lives of thousands of patients and, enabling them to be shining successes

Sponsors will receive a range of benefits and be publicly recognised in return. You will raise your brand profile at the leading edge of global scientific research and medical arenas, Your attendees can build valuable new connections with 250 influential individuals in the ophthalmology, genetics and aniridia communities

Read how to sponsor us
Sponsors

Who’s Speaking

Proposed speakers

Tony Moore
Tony Moore(Emeritus) Professor of Ophthalmology. University of California, San Francisco, UCL IoO

After training at the Oxford and Moorfields Eye Hospitals Tony undertook a two-year fellowship in Paediatric Ophthalmology at the Hospitals for Sick Children in London and Toronto.
In 1986 he moved to Addenbrooke's Hospital as a consultant with a special interest in paediatric ophthalmology and inherited eye disease.
In 2001 he moved back to London when he was appointed to the Duke Elder Chair of Ophthalmology at the UCL Institute of Ophthalmology, and Moorfields Eye Hospital
London. He retired from UCL in December 2014 when he moved to a new position as Professor of Ophthalmology at UCSF Medical School in San Francisco. His main research interests are in inherited eye disease.

Tony Moore
Tony Moore(Emeritus) Professor of Ophthalmology. University of California, San Francisco, UCL IoO

After training at the Oxford and Moorfields Eye Hospitals Tony undertook a two-year fellowship in Paediatric Ophthalmology at the Hospitals for Sick Children in London and Toronto.
In 1986 he moved to Addenbrooke's Hospital as a consultant with a special interest in paediatric ophthalmology and inherited eye disease.
In 2001 he moved back to London when he was appointed to the Duke Elder Chair of Ophthalmology at the UCL Institute of Ophthalmology, and Moorfields Eye Hospital
London. He retired from UCL in December 2014 when he moved to a new position as Professor of Ophthalmology at UCSF Medical School in San Francisco. His main research interests are in inherited eye disease.

closepopup
Cheryl Gergory-Evans
Cheryl Gregory EvansProfessor of Developmental Biology, University of British Columbia, Canada

Graduated with a PhD from the University of Strathclyde and took up a postdoctoral Fellowship at Jules Stein Eye Institute at UCLA, USA. She then returned to the Institute of Ophthalmology at UCL for 6 years before taking up a Faculty position at Imperial College London in 1997. In 2009 she was recruited to the Department of Ophthalmology at University of British Columbia in Vancouver, Canada. Her laboratory is focussed on understanding the genetic causes of childhood ocular diseases including aniridia, ocular coloboma and inherited retinal degenerations and designing targeted therapeutics strategies.

Cheryl Gergory-Evans
Cheryl Gregory EvansProfessor of Developmental Biology, University of British Columbia, Canada

Graduated with a PhD from the University of Strathclyde and took up a postdoctoral Fellowship at Jules Stein Eye Institute at UCLA, USA. She then returned to the Institute of Ophthalmology at UCL for 6 years before taking up a Faculty position at Imperial College London in 1997. In 2009 she was recruited to the Department of Ophthalmology at University of British Columbia in Vancouver, Canada. Her laboratory is focussed on understanding the genetic causes of childhood ocular diseases including aniridia, ocular coloboma and inherited retinal degenerations and designing targeted therapeutics strategies.

closepopup
Neil Lagali
Neil LagaliProfessor, Department of Ophthalmology, Linköping University, Linköping, Sweden

Prof. Lagali conducts research on corneal disease, regenerative medicine and imaging in ophthalmology. He has conducted aniridia research in Sweden, Norway, Poland and Germany, and is Chair of the European Union’s COST Action ANIRIDIA-NET (2019-2023). He is also a member of the Scientific Committee of Aniridia Europe.

Neil Lagali
Neil LagaliProfessor, Department of Ophthalmology, Linköping University, Linköping, Sweden

Prof. Lagali conducts research on corneal disease, regenerative medicine and imaging in ophthalmology. He has conducted aniridia research in Sweden, Norway, Poland and Germany, and is Chair of the European Union’s COST Action ANIRIDIA-NET (2019-2023). He is also a member of the Scientific Committee of Aniridia Europe.

closepopup
Dominique Bremond-Gignac
Dominique Bremond-GignacProfessor of Ophthalmology Head of Ophthalmology Department, University Hospital Necker-Enfants malades & Paris V Rene Descartes University

My focus is distributed in clinical practice, teaching and research, currently pediatric anterior segment, ocular surface, strabismus and oculo-plastic surgery.

Dominique Bremond-Gignac
Dominique Bremond-GignacProfessor of Ophthalmology Head of Ophthalmology Department, University Hospital Necker-Enfants malades & Paris V Rene Descartes University

My focus is distributed in clinical practice, teaching and research, currently pediatric anterior segment, ocular surface, strabismus and oculo-plastic surgery.

closepopup
Mariya Moosajee
Mariya MoosajeeConsultant Ophthalmic Surgeon and Clinical Academic Ophthalmologist. Moorfields, GOSH, UCL IoO

Specialises in genetic eye disease including aniridia, anterior segment dysgenesis, congenital cataracts, glaucoma, microphthalmia, anophthalmia and ocular coloboma and inherited retinal diseases.

Mariya Moosajee
Mariya MoosajeeConsultant Ophthalmic Surgeon and Clinical Academic Ophthalmologist. Moorfields, GOSH, UCL IoO

Specialises in genetic eye disease including aniridia, anterior segment dysgenesis, congenital cataracts, glaucoma, microphthalmia, anophthalmia and ocular coloboma and inherited retinal diseases.

closepopup
Sajjad Ahmed
Sajjad AhmedConsultant ophthalmic surgeon, Moorfields, UCL IoO

He has clinical and basic science research interest in aniridia related keratopathy (ARK), the corneal changes associated with aniridia and PAX6 mutations. His interest is in the developed of novel stem cell-based therapies for the corneal disease.

Sajjad Ahmed
Sajjad AhmedConsultant ophthalmic surgeon, Moorfields, UCL IoO

He has clinical and basic science research interest in aniridia related keratopathy (ARK), the corneal changes associated with aniridia and PAX6 mutations. His interest is in the developed of novel stem cell-based therapies for the corneal disease.

closepopup
Julie Daniels
Julie DanielsProfessor of Regenerative Medicine & Cellular Therapy. UCL IoO

Director of Cells for Sight Stem Cell Therapy Research Unit: a MHRA licensed state-of-the-art GMP facility available to academic and commercial researchers for the manufacture of Advanced Therapy Medicinal Products.
Member of Aniridia Europe Committee.

Julie Daniels
Julie DanielsProfessor of Regenerative Medicine & Cellular Therapy. UCL IoO

Director of Cells for Sight Stem Cell Therapy Research Unit: a MHRA licensed state-of-the-art GMP facility available to academic and commercial researchers for the manufacture of Advanced Therapy Medicinal Products.
Member of Aniridia Europe Committee.

closepopup
John Mason
John MasonReader in Developmental Neurobiology, University of Edinburgh

I’m interested in understanding the molecular mechanisms that regulate embryonic development of the forebrain and how disorders can arise when these developmental mechanisms are perturbed. We use a wide range of techniques in our work including cerebral organoids and the generation and analysis of genetically modified mice.

John Mason
John MasonReader in Developmental Neurobiology, University of Edinburgh

I’m interested in understanding the molecular mechanisms that regulate embryonic development of the forebrain and how disorders can arise when these developmental mechanisms are perturbed. We use a wide range of techniques in our work including cerebral organoids and the generation and analysis of genetically modified mice.

closepopup
Guy Rutter
Guy RutterProfessor Guy A. Rutter, PhD Head of Cell Biology and Functional Genomics, Faculty of Medicine, Imperial College London

Rutter trained in Cell Biology and Biochemistry at the University of Bristol before Fellowships in Geneva, Switzerland, and Bristol. He became Professor of Biochemistry in Bristol in 2002 and moved to Imperial College London in 2006. A Welcome Trust Investigator and Director of the Imperial Network of Excellence in Diabetes, his research focus is on the genetic and environmental drivers of type 2 diabetes. A former Royal Society Merit Award holder, he was awarded the Minkowski Prize of the European Association for the Study of Diabetes in 2004 and the Dorothy Hodgkin Lecture of Diabetes UK in 2014. Rutter is also Visiting Professor at Nan Yang Technological College, Singapore and the University of California, San Francisco.

Guy Rutter
Guy RutterProfessor Guy A. Rutter, PhD Head of Cell Biology and Functional Genomics, Faculty of Medicine, Imperial College London

Rutter trained in Cell Biology and Biochemistry at the University of Bristol before Fellowships in Geneva, Switzerland, and Bristol. He became Professor of Biochemistry in Bristol in 2002 and moved to Imperial College London in 2006. A Welcome Trust Investigator and Director of the Imperial Network of Excellence in Diabetes, his research focus is on the genetic and environmental drivers of type 2 diabetes. A former Royal Society Merit Award holder, he was awarded the Minkowski Prize of the European Association for the Study of Diabetes in 2004 and the Dorothy Hodgkin Lecture of Diabetes UK in 2014. Rutter is also Visiting Professor at Nan Yang Technological College, Singapore and the University of California, San Francisco.

closepopup
Jay Self
Jay SelfAssociate Professor, Consultant Ophthalmologist, University of Southampton

I lead regional paediatric cataract, nystagmus and oculo-genetic services and am a member of the RCOphth genomics working group and paediatric and academic sub-committees. I lead a research group with an interest in paediatric ophthalmic disorders including aniridia / nystagmus / albinism / retinal disorders and is a scientific advisor for 3 charities and ambassador for the David Katz foundation.

Jay Self
Jay SelfAssociate Professor, Consultant Ophthalmologist, University of Southampton

I lead regional paediatric cataract, nystagmus and oculo-genetic services and am a member of the RCOphth genomics working group and paediatric and academic sub-committees. I lead a research group with an interest in paediatric ophthalmic disorders including aniridia / nystagmus / albinism / retinal disorders and is a scientific advisor for 3 charities and ambassador for the David Katz foundation.

closepopup
Stephen Tuft
Stephen TuftConsultant Ophthalmic Surgeon, Moorfields

I have specialist interest in corneal and external eye disease. I have experience in the management of the corneal and cataract complications associated with aniridia.

Stephen Tuft
Stephen TuftConsultant Ophthalmic Surgeon, Moorfields

I have specialist interest in corneal and external eye disease. I have experience in the management of the corneal and cataract complications associated with aniridia.

closepopup
Kelly Trout
Kelly TroutDirector, Research and Medical Advocacy, International WAGR Syndrome Association

Kelly Trout co-founded the International WAGR Syndrome Association (IWSA) in 2000. She assists families, clinicians, and researchers, manages the WAGR Syndrome Patient Registry, and has written numerous articles on this disorder for professional, lay, and web publications.

Kelly Trout
Kelly TroutDirector, Research and Medical Advocacy, International WAGR Syndrome Association

Kelly Trout co-founded the International WAGR Syndrome Association (IWSA) in 2000. She assists families, clinicians, and researchers, manages the WAGR Syndrome Patient Registry, and has written numerous articles on this disorder for professional, lay, and web publications.

closepopup
Helena Lee
Helena LeeAssociate Professor, Consultant Ophthalmologist, University of Southampton

Specialises in neuro-ophthalmology, paediatrics and strabismus and has an international research reputation in the area of infantile nystagmus, pediatric retinal development and optical coherence tomography (OCT). She has recently been awarded an MRC Clinician Scientist fellowship to investigate the role of Oral Levodopa in improving Visual development in Infants and young children with Albinism (the OLIVIA study).

Helena Lee
Helena LeeAssociate Professor, Consultant Ophthalmologist, University of Southampton

Specialises in neuro-ophthalmology, paediatrics and strabismus and has an international research reputation in the area of infantile nystagmus, pediatric retinal development and optical coherence tomography (OCT). She has recently been awarded an MRC Clinician Scientist fellowship to investigate the role of Oral Levodopa in improving Visual development in Infants and young children with Albinism (the OLIVIA study).

closepopup
Nikki Hall
Nikki HallOphthalmology Registrar at the Princess Alexandra Eye Pavilion, Edinburgh

Since 2016 has been working in the lab of Prof David FitzPatrick (MRC Human Genetics Unit, IGMM) undertaking a Wellcome Trust-funded PhD investigating the genetic and development basis of PAX6-negative aniridia. Has aspecial interest in paediatric ophthalmology
She has family members with aniridia
Wellcome Trust ECAT Clinical Lecturer

Nikki Hall
Nikki HallOphthalmology Registrar at the Princess Alexandra Eye Pavilion, Edinburgh

Since 2016 has been working in the lab of Prof David FitzPatrick (MRC Human Genetics Unit, IGMM) undertaking a Wellcome Trust-funded PhD investigating the genetic and development basis of PAX6-negative aniridia. Has aspecial interest in paediatric ophthalmology
She has family members with aniridia
Wellcome Trust ECAT Clinical Lecturer

closepopup
Galina Gening
Galina GeningPresident of Aniridiai Russia, parent of child with aniridia

Parent of child with aniridia

Galina Gening
Galina GeningPresident of Aniridiai Russia, parent of child with aniridia

Parent of child with aniridia

closepopup
Keith Spink
Keith SpinkPerson with aniridia

Keith inherited aniridia, is the son visually impaired parents, and leads an independent life, including his full-time role as Head of Digital and Communications at Social Care Institute for Excellence‎

Keith Spink
Keith SpinkPerson with aniridia

Keith inherited aniridia, is the son visually impaired parents, and leads an independent life, including his full-time role as Head of Digital and Communications at Social Care Institute for Excellence‎

closepopup
Beth Dawes
Beth DawesPerson with aniridia

I am a mum of two, one of who also has aniridia. We live in Newcastle with my husband. I work part time as a call taker for North East Ambulance Service, in my spare time I like to run with the assistance of a guide runner.

Beth Dawes
Beth DawesPerson with aniridia

I am a mum of two, one of who also has aniridia. We live in Newcastle with my husband. I work part time as a call taker for North East Ambulance Service, in my spare time I like to run with the assistance of a guide runner.

closepopup
Charles Bloch
Charles BlochPerson with aniridia

A 26-year-old, who is registered blind and has only approximately 10% vision remaining. This is a result of him having aniridia, nystagmus, cataracts and glaucoma.

Charles Bloch
Charles BlochPerson with aniridia

A 26-year-old, who is registered blind and has only approximately 10% vision remaining. This is a result of him having aniridia, nystagmus, cataracts and glaucoma.

closepopup
Georgina Clements
Georgina ClementsPerson with aniridia
Georgina Clements
Georgina ClementsPerson with aniridia
closepopup

Testimonials

Professional’s opinions of past and future European Aniridia Conferences

Veronica van Heyningen CBE
Veronica van Heyningen CBEHonorary Professor, UCL

“Bringing together patients, clinicians and scientists in one meeting is the most productive path to developing new disease management and therapeutic approaches.
The 5th EAC will discuss corneal disease stem cell therapy and mutation-dependent drug treatments.”

Melanie Hingarani
Melanie HingaraniConsultant ophthalmic surgeon, Moorfields

“I want to explore the practicalities of care for patients. Routine diagnosis, treatment and monitoring of aniridia is not well understood by many. At the EAC we can disseminate and agree consistent pathways.”

Julie Daniels
Julie DanielsProf Regenerative Medicine & Cellular Therapy, UCL IoO

"The EAC is highly valued because they bring together excellence in both fundamental scientific research and clinical practice, while at the same time providing opportunity for friendly and open engagement with patients.
I anticipate that this meeting will also be a vibrant and informative event, especially as the critical mass of clinicians and scientists rising to meet the challenges of understanding the role of genetic mutation in aniridia all the way through to clinical trials of novel therapies is growing”

Nikki Hall
Nikki HallECAT Clinical Lecturer, Ophthalmolgoy Registrar, University of Edinburgh

"What I like most is the mix of people and good speakers. I love that professionals, scientists and patients are together to advance science and patient care.
It is a great chance to meet people from different backgrounds who have an interest in aniridia research."

Contact Us

Send us a message

If you have any questions or just want to get in touch, use the form below. We look forward to hearing from you!